Concourse Financial Group Securities’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-230
Closed -$5.05K 2416
2023
Q2
$4.71K Hold
230
﹤0.01% 1848
2023
Q1
$3.47K Hold
230
﹤0.01% 1952
2022
Q4
$5.48K Hold
230
﹤0.01% 1825
2022
Q3
$8K Hold
230
﹤0.01% 1553
2022
Q2
$8K Hold
230
﹤0.01% 1742
2022
Q1
$11K Sell
230
-124
-35% -$6.87K ﹤0.01% 1661
2021
Q4
$27K Hold
354
﹤0.01% 1537
2021
Q3
$38K Hold
354
﹤0.01% 1424
2021
Q2
$47K Buy
354
+30
+9% +$3.49K ﹤0.01% 1342
2021
Q1
$40K Sell
324
-82
-20% -$12.5K ﹤0.01% 1310
2020
Q4
$57K Hold
406
﹤0.01% 1115
2020
Q3
$31K Hold
406
﹤0.01% 1227
2020
Q2
$18K Sell
406
-67
-14% -$2.4K ﹤0.01% 1344
2020
Q1
$14K Buy
473
+273
+137% +$7.34K ﹤0.01% 1361
2019
Q4
$4K Hold
200
﹤0.01% 1716
2019
Q3
$5K Buy
+200
New +$5.81K ﹤0.01% 1341

Other funds holding TWST

Concourse Financial Group Securities's TWST Position: Q3 2023 in Review

Concourse Financial Group Securities sold out of Twist Bioscience (TWST) in Q3 2023, closing a stake of 230 shares — an estimated $5.05K sold.

Concourse Financial Group Securities first reported a position in TWST in Q3 2019 and held it in 16 quarters. The position peaked at $57K in Q4 2020. 194 funds tracked by Wall St. Rank hold TWST as of Q3 2023.

  • Concourse Financial Group Securities reported no remaining Twist Bioscience position as of Q3 2023 after selling out during the quarter.
  • Concourse Financial Group Securities sold 230 Twist Bioscience shares in Q3 2023, an estimated $5.05K.
  • Concourse Financial Group Securities first reported a position in Twist Bioscience in Q3 2019 and held it in 16 quarters.
  • Concourse Financial Group Securities's Twist Bioscience position peaked at $57K in Q4 2020.
  • 194 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2023.

Based on Concourse Financial Group Securities's 13F filing for Q3 2023, filed 25 Oct 2023.